Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells

Treatment options for COVID-19 are currently limited. Drugs reducing both viral loads and SARS-CoV-2-induced inflammatory responses would be ideal candidates for COVID-19 therapeutics. Previous in vitro and clinical studies suggest that the proprietary Pelargonium sidoides DC. root extract EPs 7630...

Descripción completa

Detalles Bibliográficos
Autores principales: Papies, Jan, Emanuel, Jackson, Heinemann, Nicolas, Kulić, Žarko, Schroeder, Simon, Tenner, Beate, Lehner, Martin D., Seifert, Georg, Müller, Marcel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573200/
https://www.ncbi.nlm.nih.gov/pubmed/34759825
http://dx.doi.org/10.3389/fphar.2021.757666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573200/
https://www.ncbi.nlm.nih.gov/pubmed/34759825
http://dx.doi.org/10.3389/fphar.2021.757666

Ejemplares similares